Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2018 Feb 13;8(2):e020319.
doi: 10.1136/bmjopen-2017-020319.

Wool-derived keratin dressings versus usual care dressings for treatment of slow-healing venous leg ulceration: study protocol for a randomised controlled trial (Keratin4VLU)

Affiliations
Randomized Controlled Trial

Wool-derived keratin dressings versus usual care dressings for treatment of slow-healing venous leg ulceration: study protocol for a randomised controlled trial (Keratin4VLU)

Andrew Jull et al. BMJ Open. .

Abstract

Introduction: Keratins, filament-forming proteins found in vertebrate epithelium, are downregulated in slow-healing venous leg ulcers (VLU) compared with normal-healing VLU. Laboratory and animal model research has suggested exogenous keratins increase expression of endogenous keratins. A non-randomised controlled trial of an exogenous keratin dressing reported increased healing in slow-healing VLU. To date, no randomised controlled trial has been done to verify these promising findings.

Methods and analysis: The Keratin4VLU trial is a single-blind, pragmatic, parallel group, randomised controlled trial of keratin dressings compared with usual care non-medicated dressings in patients with VLU where either (1) the ulcer area is greater than 5 cm2, (2) the ulcer has been present for more than 26 weeks or (3) both. All patients will receive compression therapy. The primary outcome is the proportion of patients with healed VLU at 24 weeks after randomisation as adjudicated by blinded review of an ulcer photograph. Secondary outcomes are time to healing, estimated change in ulcer area, change in health-related quality of life, agreement between blinded and unblinded assessors and adverse events. The analysis will be intention-to-treat on the primary and secondary outcomes (excepting health-related quality of life).

Ethics and dissemination: The Keratin4VLU trial received ethical approval from the Northern A Health and Disability Ethics Committee. We plan to publish the results within 1 year of trial completion and will include the results on the trial registration page.

Trial registration number: NCT02896725; Pre-results.

Keywords: bandages and dressings; keratin; skin substitutes; venous leg ulcer; wound healing.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Detailed trial schematic showing participant contacts and measures. HRQoL, health-related quality of life; PIS, participant information sheet.

References

    1. Margolis DJ, Berlin JA, Strom BL. Which venous leg ulcers will heal with limb compression bandages? Am J Med 2000;109:15–19. 10.1016/S0002-9343(00)00379-X - DOI - PubMed
    1. Iglesias C, Nelson EA, Cullum NA, et al. . VenUS I: a randomised controlled trial of two types of bandage for treating venous leg ulcers. Health Technol Assess 2004;8:iii, 1-105 10.3310/hta8290 - DOI - PubMed
    1. Ashby RL, Gabe R, Ali S, et al. . VenUS IV (Venous leg Ulcer Study IV) - compression hosiery compared with compression bandaging in the treatment of venous leg ulcers: a randomised controlled trial, mixed-treatment comparison and decision-analytic model. Health Technol Assess 2014;18:1–294. 10.3310/hta18570 - DOI - PMC - PubMed
    1. Jull A, Walker N, Parag V, et al. . Randomized clinical trial of honey-impregnated dressings for venous leg ulcers. Br J Surg 2008;95:175–82. 10.1002/bjs.6059 - DOI - PubMed
    1. Dumville JC, Worthy G, Bland JM, et al. . Larval therapy for leg ulcers (VenUS II): randomised controlled trial. BMJ 2009;338:b773 10.1136/bmj.b773 - DOI - PMC - PubMed

Publication types

Associated data

LinkOut - more resources